A methodological primer of extracellular vesicles isolation and characterization via different techniques.

PEG 8000 exosome extraction polymer ultracentrifugation ultrafiltration

Journal

Biology methods & protocols
ISSN: 2396-8923
Titre abrégé: Biol Methods Protoc
Pays: England
ID NLM: 101693064

Informations de publication

Date de publication:
2024
Historique:
received: 14 01 2024
revised: 02 02 2024
accepted: 12 02 2024
medline: 1 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: epublish

Résumé

We present four different protocols of varying complexity for the isolation of cell culture-derived extracellular vesicles (EVs)/exosome-enriched fractions with the objective of providing researchers with easily conducted methods that can be adapted for many different uses in various laboratory settings and locations. These protocols are primarily based on polymer precipitation, filtration and/or ultracentrifugation, as well as size-exclusion chromatography (SEC) and include: (i) polyethylene glycol and sodium chloride supplementation of the conditioned medium followed by low-speed centrifugation; (ii) ultracentrifugation of conditioned medium; (iii) filtration of conditioned media through a 100-kDa exclusion filter; and (iv) isolation using a standard commercial kit. These techniques can be followed by further purification by ultracentrifugation, sucrose density gradient centrifugation, or SEC if needed and the equipment is available. HEK293 and SH-SY5Y cell cultures were used to generate conditioned medium containing exosomes. This medium was then depleted of cells and debris, filtered through a 0.2-µM filter, and supplemented with protease and RNAse inhibitors prior to exosomal isolation. The purified EVs can be used immediately or stably stored at 4°C (up to a week for imaging or using intact EVS downstream) or at -80°C for extended periods and then used for biochemical study. Our aim is not to compare these methodologies but to present them with descriptors so that researchers can choose the "best method" for their work under their individual conditions.

Identifiants

pubmed: 38425334
doi: 10.1093/biomethods/bpae009
pii: bpae009
pmc: PMC10902684
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bpae009

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Farhang Aliakbari (F)

Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Noah B Stocek (NB)

Department of Physics and Astronomy, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Maxximuss Cole-André (M)

Department of Physics and Astronomy, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Janice Gomes (J)

Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Giovanni Fanchini (G)

Department of Physics and Astronomy, University of Western Ontario, London, Ontario N6A 3K7, Canada.
Department of Chemistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Stephen H Pasternak (SH)

Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.
Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Gunna Christiansen (G)

Department of Health Science and Technology, The Faculty of Medicine, Medical Microbiology and Immunology, Aalborg University, Aalborg Ø 9220, Denmark.

Dina Morshedi (D)

Bioprocess Engineering Department, Institute of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, P.O. Box 14965/161, Iran.

Kathryn Volkening (K)

Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.
Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Michael J Strong (MJ)

Molecular Medicine Group, Robarts Research Institute, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.
Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario N6A 3K7, Canada.

Classifications MeSH